» Articles » PMID: 33009692

Prognostic Value of Immune-related Genes and Immune Cell Infiltration Analysis in the Tumor Microenvironment of Head and Neck Squamous Cell Carcinoma

Overview
Journal Head Neck
Date 2020 Oct 3
PMID 33009692
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Head and neck squamous cell carcinoma (HNSCC) is one of the few malignant tumors that respond well to immunotherapy. We aimed to investigate the immune-related genes and immune cell infiltration of HNSCC and construct a predictive model for its prognosis.

Methods: We calculated the stromal/immune scores of patients with HNSCC from The Cancer Genome Atlas using the Estimation of STromal and Immune cells in MAlignant Tumor tissues using Expression data algorithm and investigated the relationship between the scores and patients' prognosis. Three machine learning algorithms (LASSO, Random Forest, and Rbsurv) were performed to screen key immune-related genes and constructed a predictive model. The immune cell infiltrating was calculated by the Tumor Immune Estimation Resource algorithm.

Results: The stromal and immune scores significantly correlated with prognosis. A 6-gene signature was selected and displayed a robust predictive effect. The expressions of key genes were associated with immune infiltrating. GSE65858 validated the results.

Conclusion: Our study comprehensively analyzed the tumor microenvironment of HNSCC and constructed a robust predictive model, providing a basis for further investigation of therapy.

Citing Articles

The impact of the tumor immune microenvironment and tumor-infiltrating lymphocyte subgroups on laryngeal cancer prognosis.

Tevetoglu F, Comunoglu N, Yener H Sci Prog. 2024; 107(3):368504241266087.

PMID: 39044316 PMC: 11271122. DOI: 10.1177/00368504241266087.


Validation of a Machine Learning Model to Predict Immunotherapy Response in Head and Neck Squamous Cell Carcinoma.

Lee A, Valero C, Yoo S, Vos J, Chowell D, Morris L Cancers (Basel). 2024; 16(1).

PMID: 38201602 PMC: 10778506. DOI: 10.3390/cancers16010175.


Building an Immune-Related Genes Model to Predict Treatment, Extracellular Matrix, and Prognosis of Head and Neck Squamous Cell Carcinoma.

Yang Y, Feng Y, Liu Q, Yin J, Cheng C, Fan C Mediators Inflamm. 2023; 2023:6680731.

PMID: 37469759 PMC: 10353907. DOI: 10.1155/2023/6680731.


Construction of the prognostic signature of alternative splicing revealed the prognostic predictor and immune microenvironment in head and neck squamous cell carcinoma.

Ye F, Wu P, Zhu Y, Huang G, Tao Y, Liao Z Front Genet. 2022; 13:989081.

PMID: 36338975 PMC: 9633855. DOI: 10.3389/fgene.2022.989081.


Combination of Tumor Mutational Burden and DNA Damage Repair Gene Mutations with Stromal/Immune Scores Improved Prognosis Stratification in Patients with Lung Adenocarcinoma.

Wu D, Huang L, Mao J, Liu J, Ye W, Xu J J Oncol. 2022; 2022:6407344.

PMID: 36262349 PMC: 9576425. DOI: 10.1155/2022/6407344.